Article
Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines
29 Jun 2021
Abstract excerpt
Glioblastoma multiform (GBM) is one of the most severe tumor types. It is highly invasive and characterized as a grade IV neoplastic cancer. Its resistance to chemotherapy-temozolomide (TMZ treatment)-in combination with tumor treating fields (TTFields), limits the cure of GBM. Therefore researchers are searching for new treatment options to increase the length of recurrence time and improve overall survival for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
